KALV (STOCKS)
KalVista Pharmaceuticals, Inc. Common Stock
$15.120000
-0.390000 (-2.51%)
Prev close: $15.510000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Benjamin L. Palleiko
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $764.26M
- Employees
- 270
- P/E (TTM)
- -3.78
- P/B (TTM)
- 19.14
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q1)
|
$-1.12 | $-0.97 | -0.1476 | -15.18% |
|
Jun 2025 (Q4)
|
$-0.99 | $-0.80 | -0.1933 | -24.26% |
|
Mar 2025 (Q3)
|
$-0.78 | $-0.89 | +0.1115 | +12.51% |
|
Dec 2024 (Q2)
|
$-0.91 | $-0.93 | +0.0162 | +1.75% |
Financial Statements
| Assets | $339.93M |
| Current Assets | $325.23M |
| Accounts Receivable | $5.78M |
| Inventory | $458.00K |
| Other Current Assets | $318.99M |
| Noncurrent Assets | $14.71M |
| Fixed Assets | $3.19M |
| Other Non-current Assets | $11.52M |
| Liabilities | $322.93M |
| Current Liabilities | $45.07M |
| Accounts Payable | $8.07M |
| Wages | $11.00M |
| Other Current Liabilities | $26.00M |
| Noncurrent Liabilities | $277.86M |
| Equity | $17.00M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $17.00M |
| Liabilities And Equity | $339.93M |